Early Access — free while we kick the tires
EdgarHawk

JOYCE CHRISTOPHER J

Chief Legal and Admin. Officer

Officer
2 filings analyzed · 1 company · Latest 2025-09-10

Companies

Company Buys Sells Direction
Alignment Healthcare, Inc. ALHC 0 5 Net selling

Activity

September 2025
medium
Sell
30,939 shares
$507,636
Significance 6/10

Chief Legal Officer Joyce Christopher J sells 30,939 shares at $16.23–$16.86 for $507,635.76 at ALHC; 100% of prior ALHC sales were well-timed.

Joyce Christopher J, Chief Legal and Administrative Officer, executed 2 separate sales totaling 30,939 shares for $507,635.76 on 2025-09-10, reducing holdings from 374,531 to 343,592 shares (-8.3%). His prior trades at ALHC show a 100% well-timed sell rate (2 of 2 prior sales followed by negative 90-day returns at -1.4% and -0.5%), suggesting a pattern of selling ahead of price weakness. The current stock price of $16.45 sits -16.8% from the 52-week high of $19.78, yet the stock has rallied +12.6% over the past 30 days. The company reported FY net income in the negative despite $1,015,288,000.00 in revenue and +48.2% annual revenue growth, indicating profitability remains under pressure despite strong top-line expansion. The timing of this open-market sale by a senior executive, viewed against the company's net loss position and this insider's established pattern of well-timed exits at this ticker, merits monitoring of near-term price action and quarterly guidance.

March 2025
medium
Sell
35,871 shares
$558,442
Significance 4/10

Chief Legal Officer sells 35,871 shares at $15.57 blended average; retains 387.0K shares post-sale

Christopher J Joyce, Chief Legal and Admin. Officer, executed 2 separate sales totaling 35,871 shares for $558,441.63 on March 4–6, 2025, at a blended average price of $15.57. Post-transaction, he retains 387.0K shares against pre-transaction holdings of 422.8K shares, representing an 8.5% reduction in his stake. The sales occurred near the 52-week high ($15.81), with the company currently trading at $15.25 (-3.5% from the peak). ALHC is unprofitable (net income $-26.4M in its most recent full fiscal year) despite strong revenue growth of +48.2% year-over-year, presenting a classic high-growth but cash-negative profile. The officer's substantial remaining position (387.0K shares) suggests continued material exposure to the company's execution and path to profitability.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access